Prostate Cancer Screening
Description
More than one in six men will develop prostate cancer in their lifetime. In recent years there has been an explosion of information regarding PSA screening and biomarkers for the disease. In Prostate Cancer Screening, Second Edition, the world's leading experts on prostate cancer detection update the first edition with the latest findings. The book incorporates a series of thoughtful and cutting-edge works from the world's experts in prostate cancer screening, ranging from the current status quo of prostate cancer screening across the globe to consensus on optimal utilization of the traditional PSA and DRE tests, to cutting-edge research in new biomarkers, biomeasures, and extended risk algorithms for prostate cancer. An additional chapter covers family-based linkage analysis as well as possible pitfalls in prostate cancer biomarker evaluation studies. Timely and authoritative, Prostate Cancer Screening, Second Edition, is an essential text for urologists, oncologists and family physicians, as well as researchers in the biomarker industry who seek methods to better develop and support markers and measures of prostate cancer.
Reviews / Votes
This book describes in depth the current status of PSA screening as well as other diagnostic tools. The book also includes a compact disk with a program that can calculate risk of developing prostate cancer. The book is well written and readable, not only for the specialist, but also the interested physician, trainee or student. - Oncology "...offers valuable background information for urologists and family physicians" - Clinical Chemistry Comprehensive and balanced, Prostate Cancer Screening, presents a lively and rigorous evaluation of the science of prostate cancer screening, affording the health care provider with an informative discussion of its pros and cons, together with user-friendly computer program that analyzes an individual patient's risk of prostate cancer. - TumoriMore details
Other editions
New editions
Additional editions
Content
Wael A. Sakr and Clara Ward
Natural History of Prostate Cancer
Peter C. Albertsen
Mathematical Issues: PSA Testing
Ruth Etzioni and David F. Penson
Evidence of Benefit of Screening in Other Cancers
Ismail Jatoi
The Role of Prostate Specific Antigen and Its Variants in Prostate Cancer Screening
Faiyaaz M. Jhaveri, Michael K. Brawer, and Eric A. Klein
The Digital Rectal Examination in Prostate Cancer Screening
Joseph Basler
Philosophical Reflections on PSA Screening: What Should We Now Think and Do?
Paul H. Lange
Imaging in Prostate Cancer Screening
Aaron Sulman and Martin I. Resnick
Risk Factors for Prostate Cancer
David L. Shepherd
Transrectal Ultrasound and Artifical Neural Networks in the Diagnosis of Prostate Cancer
Tillmann Loch
Evidence of the Effectiveness of Prostate Cancer Screening
Chris Magee and Ian M. Thompson
Prostate Cancer Screening: A Note of Caution
Otis W. Brawley
Quality of Life and Health Behavior in Prostate Cancer Screening Populations
Mark S. Litwin and Kristen A. Reid
Prostate Cancer Screening Recommendations from Organized Medicine
Gregory T. Sweat
Informed Consent and Prostate Specific Antigen Screening: What Patients Ought to Know
Evelyn C. Y. Chan
Experience of Prostate Cancer Awareness Week
Zinelabidine Abouelfadel and E. David Crawford
The Laval University Screening Trial Results
Fernand Labrie, Bernard Candas, Lionel Cusan, and Jose-Luis Gomez
Cancer of the Prostate Risk Index Test and Software (CAPRI)
Scott A. Optenberg, Atanacio C. Guillen, John P. Campbell, and Ian M. Thompson
The European Randomized Study of Screening for Prostate Cancer (ERSPC)
Fritz H. Schröder and Ingrid van der Cruijsen-Koeter for the ERSPCStudy Group